Oceania (exc. Australia and New Zealand) vs Uruguay: Proportion of the target population who received
Oceania (exc. Australia and New Zealand)
34.0%
in 2024
Uruguay
95.0%
in 2024
Oceania (exc. Australia and New Zealand) rank
37th
Uruguay rank
36th
Proportion of the target population who received over time
- Oceania (exc. Australia and New Zealand)
- Uruguay
How they compare
Uruguay currently reports 95.0% against 34.0% in Oceania (exc. Australia and New Zealand), a difference of 61.0%.
That makes Uruguay's figure about 2.8 times Oceania (exc. Australia and New Zealand)'s.
Across all 12 years both countries report, Uruguay has been ahead every year.
Oceania (exc. Australia and New Zealand) ranks 37th and Uruguay ranks 36th of 37 groups.
Uruguay has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Oceania (exc. Australia and New Zealand) | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 12.7% | 93.1% | 80.4% | Uruguay |
| 2020s | 34.2% | 90.0% | 55.8% | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Oceania (exc. Australia and New Zealand) or Uruguay?
- Uruguay, at 95.0% against 34.0% in Oceania (exc. Australia and New Zealand) as of 2024.
- What is the difference in proportion of the target population who received between Oceania (exc. Australia and New Zealand) and Uruguay?
- 61.0%, with Uruguay ahead.
- How many years of comparable data are there for Oceania (exc. Australia and New Zealand) and Uruguay?
- 12 years are reported by both, from 2013 to 2024.
- How do Oceania (exc. Australia and New Zealand) and Uruguay rank globally for proportion of the target population who received?
- Oceania (exc. Australia and New Zealand) ranks 37th and Uruguay ranks 36th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.